LRRK2 and Parkinson disease: Recent tomography and cryo-EM analysis provide the first glimpse of the LRRK2 structure revealing how Parkinson's mutations and inhibitors modulate the closed and open conformation of the kinase and impact upon microtubule binding [5,6].